Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Managing Viral Emerging Infectious Diseases via current Molecular Diagnostics in the Emergency Department: the Tricky Cases
Dimitra S. Mouliou
Expert Review of Anti-infective Therapy (2022) Vol. 20, Iss. 9, pp. 1163-1169
Closed Access | Times Cited: 11

Showing 11 citing articles:

C-Reactive Protein: Pathophysiology, Diagnosis, False Test Results and a Novel Diagnostic Algorithm for Clinicians
Dimitra S. Mouliou
Diseases (2023) Vol. 11, Iss. 4, pp. 132-132
Open Access | Times Cited: 40
Current Evidence in SARS-CoV-2 mRNA Vaccines and Post-Vaccination Adverse Reports: Knowns and Unknowns
Dimitra S. Mouliou, Efthimios Dardiotis
Diagnostics (2022) Vol. 12, Iss. 7, pp. 1555-1555
Open Access | Times Cited: 39
COVID-19 in patients with anemia and haematological malignancies: risk factors, clinical guidelines, and emerging therapeutic approaches
Sareh Kakavandi, Bahareh Hajikhani, Paniz Azizi, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7
Key insights into recent advances and challenges in COVID-19 management
Prakash Monika, Anushka A. Poola, Prithvi S. Prabhu, et al.
Deleted Journal (2025) Vol. 22, Iss. 1
Open Access
The onset of de novo autoantibodies in healthcare workers after mRNA based anti-SARS-CoV-2 vaccines: a single centre prospective follow-up study
Maria Cristina Sacchi, Carolina Pelazza, Marinella Bertolotti, et al.
Autoimmunity (2023) Vol. 56, Iss. 1
Open Access | Times Cited: 14
Changes in the intrinsic severity of severe acute respiratory syndrome coronavirus 2 according to the emerging variant: a nationwide study from February 2020 to June 2022, including comparison with vaccinated populations
Boyeong Ryu, Eunjeong Shin, Dong-Hwi Kim, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Chatbots in Cancer Applications, Advantages and Disadvantages: All that Glitters Is Not Gold
G. Goumas, Theodoros Dardavesis, Konstantinos Syrigos, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 8, pp. 877-877
Open Access | Times Cited: 4
The Deceptive COVID-19: Lessons from Common Molecular Diagnostics and a Novel Plan for the Prevention of the Next Pandemic
Dimitra S. Mouliou
Diseases (2023) Vol. 11, Iss. 1, pp. 20-20
Open Access | Times Cited: 8
John Cunningham Virus and Progressive Multifocal Leukoencephalopathy: A Falsely Played Diagnosis
Dimitra S. Mouliou
Diseases (2024) Vol. 12, Iss. 5, pp. 100-100
Open Access | Times Cited: 2
Assessment of the Levels of TGF-β1 and IL-18 in Gastritis Patients Infected with Helicobacter pylori
Ahoodabd Alhussen Habeeb
JOURNAL OF COMMUNICABLE DISEASES (2024) Vol. 56, Iss. 01, pp. 99-105
Open Access | Times Cited: 1
The effectiveness of single and two-dose Pfizer-BioNTech vaccine against SARS-COV-2: A real-world evidence from Saudi Arabia
Yasser Albogami, Abdulaziz Alalwan, Mohammed A. Batais, et al.
Journal of Infection and Public Health (2023) Vol. 16, Iss. 12, pp. 1898-1903
Open Access
Page 1

Scroll to top